REDMILE β 2021 Investments
7 investments dated 2021 Β· listed companies and verified rows first Β· show all
Invivyd develops monoclonal antibody therapies to prevent and treat serious viral infections, beginning with COVID-19 and expanding to respiratory syncytial virus and measles.
BiotechWaltham, US
Tillman U. Gerngross(Executive Officer, Director)Lynn Connolly(Executive Officer)Eric Kimble(Executive Officer)inHalley Gilbert(Executive Officer)Rebecca Dabora(Executive Officer)inEllie Hershberger(Executive Officer)
Co-investorsFidelity InvestmentsForesite CapitalGV (Google Ventures)MITHRILMithril Capital ManagementOrbiMed+3 more
GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function.
BiotechDeep TechHealthtechCambridge, US
Daniel J Mandell(Chief Executive Officer)Tracey Lodie(Executive Officer)inChristopher Gregg(Director)
BoardMing Fang(Director)Bruce Beutel(Director)Dan Becker(Director)
Co-investorsLeaps by BayerDigitalis VenturesDreamers VCRising TideAtlas VentureInnovation Endeavors+1 more
Home Biosciences was a venture builder in Continental Europe dedicated to creating and scaling biotech companies through an asset-centric, hub-and-spoke model, working with academics and scientists on drug discovery and molecular profiling projects.
AI & Machine LearningBiotechHealthtech
David Schilansky(Co-founder & Non-executive Chairman)inMagali Richard(Co-founder)in
Co-investorsSofinnova Partners
Attralus develops pan-amyloid removal (PAR) therapeutics β biologics and imaging agents designed to bind and remove toxic amyloid β to treat patients with systemic amyloidosis across all disease types and stages.
BiotechHealthtechSouth San Francisco, US
Jonathan Wall(Executive Officer)inSpencer Guthrie(Executive Officer)Mark Timney(Executive Officer, Director)inBenson Fong(Executive Officer)Rahul Kakkar(Director)inGreg Bell(Executive Officer)
Co-investorsAlpha Wave GlobalBioBritvenBio PartnersJanus Henderson InvestorsSamsara BioCapitalvenBio Global Strategic+1 more
Mnemo Therapeutics is a Paris-based clinical-stage biotech developing cell therapies using its EnfiniT epigenetic antigen discovery platform to target tumor-specific antigens for CAR-T therapies.
Co-investorsSofinnova PartnersAlexandriaCasdin Capital
Provides pharmaceutical R&D services via the Cyto-Mine machine for single-cell analysis and characterisation.
Co-investors24 HaymarketQVenturesProvidence Investment Company LimitedSofinnova Partners
Thriveworks provides therapy and psychiatric medication management services, helping clients find providers and book sessions, with insurance accepted.
Digital HealthHealthtechMedia & EntertainmentMental HealthWellness & Fitness
Anthony Centore(Executive Officer, Director)Jon Santemma(Executive Officer, Director)Terry Wang(Director)David Kim(Director)
Co-investorsRogue Insight CapitalFidelity InvestmentsRA CapitalWellington Management
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.